Qiagen N.V. (QGEN)
NYSE: QGEN
· Real-Time Price · USD
45.13
0.13 (0.29%)
At close: May 30, 2025, 3:59 PM
45.13
0.00%
After-hours: May 30, 2025, 05:16 PM EDT
Qiagen Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Diagnostic Solutions Revenue | 748.89M | 697.63M | 660.88M | 638.76M | 460.76M |
| Diagnostic Solutions Revenue Growth | +7.35% | +5.56% | +3.46% | +38.63% | n/a |
| Genomics / NGS Revenue | 233.61M | 238.91M | 224.8M | 245.07M | 165.57M |
| Genomics / NGS Revenue Growth | -2.22% | +6.28% | -8.27% | +48.01% | n/a |
| PCR / Nucleic Acid Amplification Revenue | 300.47M | 300.2M | 390.8M | 433.97M | 363.55M |
| PCR / Nucleic Acid Amplification Revenue Growth | +0.09% | -23.18% | -9.95% | +19.37% | n/a |
| Product and Service, Other Revenue | 53.22M | 65.58M | 68.11M | 83.22M | 76.6M |
| Product and Service, Other Revenue Growth | -18.84% | -3.71% | -18.17% | +8.65% | n/a |
| Sample Technologies Revenue | 642.03M | 662.99M | 796.93M | 850.64M | 803.87M |
| Sample Technologies Revenue Growth | -3.16% | -16.81% | -6.31% | +5.82% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific And Rest Of World Revenue | 298.15M | 320.68M | 410.29M | 429.86M | 362.6M | 316.96M | 318.53M | 301.17M | 282.46M | 265.92M | 273.83M | 227.16M | 234.08M | 203.67M |
| Asia Pacific And Rest Of World Revenue Growth | -7.03% | -21.84% | -4.55% | +18.55% | +14.40% | -0.49% | +5.76% | +6.62% | +6.22% | -2.89% | +20.55% | -2.96% | +14.93% | n/a |
| Emea Revenue | 648.49M | 624.57M | 733.47M | 814.42M | 682.29M | 487.48M | 490.3M | 462.98M | 428.06M | 409.95M | 451.09M | 60.17M | 42.92M | 55.14M |
| Emea Revenue Growth | +3.83% | -14.85% | -9.94% | +19.37% | +39.96% | -0.58% | +5.90% | +8.16% | +4.42% | -9.12% | +649.75% | +40.18% | -22.16% | n/a |
| Other Americas Revenue | 89.56M | 84.77M | 88.14M | 97.69M | 96.88M | 58.12M | 60.36M | 73.48M | 71.8M | 79.58M | 75.97M | 592.82M | 561.05M | 521.64M |
| Other Americas Revenue Growth | +5.64% | -3.82% | -9.77% | +0.83% | +66.69% | -3.71% | -17.85% | +2.34% | -9.78% | +4.74% | -87.18% | +5.66% | +7.56% | n/a |
| Total Americas Revenue | 1.03B | 1.02B | 997.75M | 1.01B | 825.46M | 721.99M | 693.02M | 653.38M | 627.47M | 605.11M | 619.85M | n/a | n/a | n/a |
| Total Americas Revenue Growth | +1.13% | +2.24% | -0.96% | +22.04% | +14.33% | +4.18% | +6.07% | +4.13% | +3.70% | -2.38% | n/a | n/a | n/a | n/a |
| United States Revenue | 942.01M | 935.28M | 909.62M | 909.69M | 728.58M | 663.87M | 632.66M | 579.91M | 555.68M | 525.53M | 543.88M | n/a | n/a | n/a |
| United States Revenue Growth | +0.72% | +2.82% | -0.01% | +24.86% | +9.75% | +4.93% | +9.10% | +4.36% | +5.74% | -3.37% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 137.94M | 141.71M | 140.66M | 143.3M | 138.69M | 145.95M | 140.11M | 145.52M | 147.58M | 154.21M | 145.46M | 151.42M | 152.85M | 152.27M | 143.22M | 141.41M | 147.56M | 153.07M | 130.1M | 118.24M | 123.95M | 123.6M | 125.77M | 136.22M | 133.57M | 126.38M | 128.35M | 150.74M | 128.03M | 166.94M | 128.5M | 153.72M | 124.59M | 155.6M | 127.78M | 129.56M | 119.79M | 119.43M | 113.32M | 117.31M | 114.78M |
| Selling, General, and Administrative Revenue Growth | -2.66% | +0.75% | -1.85% | +3.33% | -4.98% | +4.17% | -3.72% | -1.39% | -4.30% | +6.01% | -3.93% | -0.94% | +0.38% | +6.32% | +1.28% | -4.17% | -3.60% | +17.65% | +10.03% | -4.61% | +0.28% | -1.73% | -7.67% | +1.98% | +5.69% | -1.53% | -14.85% | +17.74% | -23.31% | +29.91% | -16.41% | +23.39% | -19.93% | +21.77% | -1.37% | +8.15% | +0.30% | +5.39% | -3.40% | +2.21% | n/a |
| Research and Development Revenue | 43.78M | 48.6M | 44.45M | 49.1M | 51.33M | 45.97M | 47.93M | 49.89M | 54.72M | 44.72M | 48.87M | 49.9M | 46.38M | 42.11M | 48.27M | 52.15M | 47.43M | 46.34M | 36.1M | 31.82M | 34.81M | 33.99M | 41.84M | 40.83M | 40.79M | 40.67M | 42.03M | 39.63M | 39.52M | 40.94M | 38.43M | 38.79M | 37.83M | 58.51M | 36.2M | 42.12M | 39.76M | 39.71M | 35.57M | 33.58M | 38.33M |
| Research and Development Revenue Growth | -9.92% | +9.34% | -9.47% | -4.34% | +11.68% | -4.11% | -3.93% | -8.82% | +22.36% | -8.49% | -2.06% | +7.59% | +10.12% | -12.75% | -7.44% | +9.94% | +2.35% | +28.39% | +13.45% | -8.60% | +2.43% | -18.78% | +2.49% | +0.10% | +0.30% | -3.24% | +6.05% | +0.28% | -3.47% | +6.54% | -0.92% | +2.53% | -35.35% | +61.62% | -14.05% | +5.94% | +0.12% | +11.65% | +5.94% | -12.40% | n/a |
| Sales and Marketing Revenue | 106.33M | 113.86M | 111.26M | 114.69M | 111.12M | 117.48M | 111.46M | 116.33M | 114.64M | 122.24M | 114.58M | 118.89M | 118.5M | 119.38M | 112.86M | 110.39M | 113.76M | 121.38M | 102.18M | 94.38M | 95.76M | 98.32M | 97.02M | 100.69M | 95.89M | 97.88M | 96.47M | 101.85M | 96.08M | 92.23M | 96.64M | 103.87M | 92.34M | 115M | 94.44M | 98.77M | 93.97M | 93.76M | 88.76M | 89.83M | 88.61M |
| Sales and Marketing Revenue Growth | -6.61% | +2.34% | -2.99% | +3.21% | -5.41% | +5.40% | -4.19% | +1.47% | -6.22% | +6.69% | -3.62% | +0.33% | -0.74% | +5.78% | +2.23% | -2.96% | -6.27% | +18.79% | +8.26% | -1.44% | -2.60% | +1.34% | -3.64% | +5.01% | -2.03% | +1.45% | -5.28% | +6.01% | +4.18% | -4.57% | -6.96% | +12.49% | -19.71% | +21.77% | -4.38% | +5.11% | +0.22% | +5.64% | -1.19% | +1.38% | n/a |